Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Present and future pharmacological approaches

N Finer1

  • 1Centre for Obesity Research, Luton and Dunstable Hospital, UK.

British Medical Bulletin
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).

Trials·2024
Same author

Pre-pregnancy weight loss in women with obesity requesting removal of their intra-uterine contraceptive device in order to conceive: a pilot study of full meal replacement.

Clinical obesity·2018
Same author

Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores.

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Commissioning guidance for weight assessment and management in adults and children with severe complex obesity.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2017
Same author

Can we reconcile 'the obesity paradox' with recent cardiovascular outcome trials in diabetes?

Clinical obesity·2017
Same author

A review of international clinical practice guidelines for the use of oxygen in the delivery room resuscitation of preterm infants.

Acta paediatrica (Oslo, Norway : 1992)·2017

Current obesity drugs show therapeutic effects, but

Area of Science:

  • Pharmacology
  • Obesity Therapeutics

Background:

  • Obesity is a complex metabolic disorder requiring effective pharmacologic interventions.
  • Current drug treatments for obesity include appetite suppressants and fat absorption inhibitors.
  • The development of obesity pharmacotherapy parallels early antihypertensive treatments.

Purpose of the Study:

  • To review the current landscape of pharmacologic treatments for obesity.
  • To assess the efficacy and side effect profiles of existing anti-obesity medications.
  • To provide a perspective on future developments in obesity drug therapy.

Main Methods:

  • Literature review of drugs affecting food intake and thermogenesis.
  • Analysis of therapeutic effects and side effect profiles of key obesity medications.

Related Experiment Videos

  • Comparative assessment of current obesity drugs with historical antihypertensive treatments.

    • Main Results:

    • Drugs like orlistat, sibutramine, and dexfenfluramine demonstrate therapeutic benefits with acceptable side effects.
    • 'Thermogenic' agents (e.g., ephedrine, caffeine) are effective but less tolerated.
    • Current obesity drug options are limited, similar to early antihypertensive therapies.

    Conclusions:

    • Pharmacologic treatment for obesity has shown progress, with several effective options available.
    • While current drugs offer benefits, there is a need for improved tolerability and efficacy.
    • The field of obesity pharmacotherapy is poised for significant advancements in the coming decade.